Scientists detect probable genetic cause of some Parkinson's disease cases
...ogressive neurologicdisorder that is caused by the degeneration of nerve cells in theportion of the brain that controls movement. Scientists have longsuspected genetics plays a role in the onset of the disease. In thesestudies, the investigators found that a mutation in the gene LRRK2appears to occur in at least ...Emory Eye Center Implants Its First Retinal Chips In Patients With Retinitis Pigmentosa
... that is hereditary and causes progressive retinal degeneration in both eyes. It is a general term for a number of diseases that predominantly affect the photoreceptor layer or "light sensing" cells of the retina. Night blindness develops, usually in childhood, followed by loss of peripheral visual field, progres...Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
...hich are characterized by progressive weakness and degeneration of the skeletal muscles which control movement. The Muscular Dystrophy Association and Genzyme Corporation supported the research. Several forms of Pompe disease affect more than 5,000 people in the U.S. If symptoms appear during infancy, the disea...Scientists identify genetic pathways essential to RNA interference
...s. An RNAi-based treatment for age-related macular degeneration is already in clinical trials." Ruvkun is a professor of Genetics at Harvard Medical School. RNAi was originally identified in the C. elegans roundworm and the flowering plant Arabidopsis thaliana, both of which are common model organisms for biolog...Gene Therapy For Parkinson's Disease Moves Forward In Animals
...ular combination of proteins prevent or accelerate degeneration of the neurons?'?said Nicholas Muzyczka, Ph.D., an eminent scholar and professor of molecular genetics and microbiology at UF's College of Medicine who participated in the research. “For some time Dr. Mandel has been working on the idea of introducin...Mouse Dopaminergic Neuron Differentiation Kit, 2nd Generation from R&D Systems
...studied catecholamine neurons, in part because the degeneration of DA neurons in the substantia nigra results in Parkinsons disease. Both animal models and clinical trials have suggested that cell replacement therapies may be effective in treating Parkinsons disease. This approach is limited, however, by the avai...... from the strain NIH Swiss. Because of the retinal degeneration ocurring after birth in the NIH Swiss background, adult eyes are prepared from the strain C57BL/6. Each slide contains 8 tissues: brain, heart, kidney, liver, lung, muscle, pancreas and spleen....Researcher wants to commercialize adult stem cell discovery
...pecific defects of the heart and bone defects like degeneration and craniofacial birth defects could be treated through neural crest stem cell replacement therapy. Sieber-Blum's research team grafted the cells into mice that have spinal cord injuries, and the cells survived and integrated into the spinal cord, r...Medical College team seeks stem cell patent
...ecific defects of the heart, and bone defects like degeneration and craniofacial birth defects, also could also be treated through neural crest stem cell replacement therapy, she added. These conditions affect more than 11 million people in the United States, and annually cost an estimated $170 billion or more. ......s Lou Gehrigs disease, which have a far more rapid degeneration than Parkinsons and force greater splits between the neurons. Through stem cell introduction, the existing neurons can be protected and given more impetus to reform connections. Stem cells are very powerful ... better than direct injection by far, S...... typical of how it robs people of their lives. His degeneration was slow, at first, but gathered momentum over time. Independence turned to dependence. At the end, Claude Richmond Still was in otherwise fine physical shape for a man of 80, but his memory and even his ability to mumble more than a cogent word or t......h Pfizer valued up to $745 million for its macular degeneration product Macugen, it appears that this IPO has been postponed to January. Acorda Therapeutics , another company with an IPO filing hoping to raise $62 million, has pulled its IPO for 2003, according to Journal . Though it looks like the action is ...Miracle cure for Alzheimer’s around the corner
...the most dreadful kind of Dementia, where there is degeneration of the brain tissue, might at last have the much awaited miracle cure round the corner. A vaccine made headlines sometime ago, as being efficient in reducing plaque formation in mice, which is characteristic of Alzheimer’s. Latest reports say that i...Role of fats and oils in vision care
...ion, according to a new study. Age-related macular degeneration (AMD) is a currently untreatable disease of the eye causing fuzziness, shadows and severe visual impairment. As the name suggests, it gets worse with age and diet has been implicated in its development. // Researchers at the Massachusetts Eye and E...... oxidative damage plays an important role in brain degeneration of the kind seen in Alzheimer's, Parkinson's and other neurological diseases. Researchers, in California, have developed a mouse model for studying oxidative damage and how to repair it.// This natural antioxidant enzyme called superoxide dismutase......ose with retinal diseases like age-related macular degeneration or retinitis pigmentosa. There are currently no effective treatments for these conditions. But there's a long way to go, say the researchers, in working out how best to translate this research into humans. They hope they will be doing at least limite...... diagnosing and treating blinding diseases.Macular degeneration affects 20 per cent of people over age 75. Discovery of the full set of photoreceptor genes expressed int he retinal cells, which was made in mice, could also lead to new methods for preserving and restoring the vision of those affected.// Photorec...PVA, The Personal Vision Assistant
...was designed with the special needs of the macular degeneration patient in mind. PVA contains many new functions including a mirror attachment to allow you to see your face to shave or put on makeup and a 350,000 pixel full color camera. It connects easily to most television.......laucoma, diabetic retinopathy, age-related macular degeneration and other retinal pathologies. The RTA is the only system in the market that covers the peripapillary, the posterior pole and the optic nerve areas in one session, the only system which displays raw, un-extrapolated data, and the only system to comb......l recently, most patients with age-related macular degeneration (AMD) could not expect their vision to improve or stabilize with or without treatment. Now, the Opal Photoactivator laser from Lumenis has revolutionized the standard of care and offers patients renewed hope. Lumenis designed the Opal Photoactivator ......cent-onset neovascular ("wet") age-related macular degeneration (AMD). This macular perimeter maps and quantifies visual field defects consistent with the progression of intermediate ("dry") AMD to the wet stage of the disease. By overcoming the brain's ability to compensate for small visual field defects, the Pr...Pharmexa A/S (DK) - Pharmexa presents data from influenza program
...companyto address critical targets in cancer, bone degeneration andAlzheimer's disease, as well as serious infectious diseases such asHIV, influenza, hepatitis and malaria. Its leading programs areGV1001, a peptide vaccine that has entered phase III trials inpancreatic cancer and phase II trials in liver cancer, ...Cogane Data Presented at ‘11th International Congress of Parkinson’s Disease and Disorders’
...l growth factors and reversesdopaminergic neuronal degeneration observed in vitro. Whenadministered orally to pre-...ible forthe control of movement. This is caused by degeneration ofdopaminergic neurones between the striatum and the substantia nigrapart of the brain leading to in...Pharmexa A/S (DK) - Long lasting immune response and survival to RAS vaccine
...companyto address critical targets in cancer, bone degeneration andAlzheimer's disease, as well as serious infectious diseases such asHIV, influenza, hepatitis and malaria. Its leading programs areGV1001, a peptide vaccine that has entered phase III trials inpancreatic cancer and phase II trials in liver cancer, ...Lpath Demonstrates 'First-in-Class' AMD Results With Its Lead Drug Candidate, Sphingomab
... standard animalmodel of human age-related macular degeneration (AMD). The results were presented at the annual meeting of theAssociation of Research in Vision and Ophthalmology (ARVO) by GlennL. Stoller, M.D., head of Lpath's ocular therapies division.Stoller reported that Lpath's lead drug candidate Sphingomab......eovascular diseasessuch as wet age-related macular degeneration (AMD) involveintravitreal injections to the eye. Both patients and doctorsdesire less frequent injections into the eye to deliver suchtherapeutics. A possible strategy is the use of gene deliverysystems to achieve sustained production of therapeutic ...